Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer’s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways
Na Zhao, Yingxue Ren, Yu Yamazaki, et al.
Neuron (2020) Vol. 106, Iss. 5, pp. 727-742.e6
Open Access | Times Cited: 191

Showing 1-25 of 191 citing articles:

APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches
Alberto Serrano‐Pozo, Sudeshna Das, Bradley T. Hyman
The Lancet Neurology (2020) Vol. 20, Iss. 1, pp. 68-80
Open Access | Times Cited: 652
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Ana‐Caroline Raulin, Sydney V. Doss, Zachary A. Trottier, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 335
Western diet as a trigger of Alzheimer’s disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration
Angelika Więckowska‐Gacek, Anna Mietelska‐Porowska, Małgorzata Wydrych, et al.
Ageing Research Reviews (2021) Vol. 70, pp. 101397-101397
Open Access | Times Cited: 238
Cholesterol and matrisome pathways dysregulated in astrocytes and microglia
Julia TCW, Qian Lü, Nina H. Pipalia, et al.
Cell (2022) Vol. 185, Iss. 13, pp. 2213-2233.e25
Open Access | Times Cited: 231
Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer’s Disease
Joseph W. Lewcock, Kai Schlepckow, Gilbert Di Paolo, et al.
Neuron (2020) Vol. 108, Iss. 5, pp. 801-821
Open Access | Times Cited: 179
APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease
Zonghua Li, Francis Shue, Na Zhao, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 175
APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer’s disease
Aivi T. Nguyen, Kui Wang, Gang Hu, et al.
Acta Neuropathologica (2020) Vol. 140, Iss. 4, pp. 477-493
Open Access | Times Cited: 169
Alzheimer’s pathogenic mechanisms and underlying sex difference
Donghui Zhu, Axel Montagne, Zhen Zhao
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 11, pp. 4907-4920
Open Access | Times Cited: 161
Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology
M. Mahafuzur Rahman, Christofer Lendel
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 153
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
Rosalía Fernández‐Calle, Sabine C. Konings, Javier Frontiñán-Rubio, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 142
Microglial metabolism is a pivotal factor in sexual dimorphism in Alzheimer’s disease
Marie‐Victoire Guillot‐Sestier, Ana Rubio Araiz, Virginia Mela, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 112
Reactive astrocytes transduce inflammation in a blood-brain barrier model through a TNF-STAT3 signaling axis and secretion of alpha 1-antichymotrypsin
Hyosung Kim, Kun Leng, Jinhee Park, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 95
APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge
Sangderk Lee, Nicholas A. Devanney, Lesley R. Golden, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112196-112196
Open Access | Times Cited: 93
Lipid-accumulated reactive astrocytes promote disease progression in epilepsy
Zhang‐Peng Chen, Suji Wang, Xiansen Zhao, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 4, pp. 542-554
Closed Access | Times Cited: 93
Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer’s Disease (EPAD) cohort
Rasha N.M. Saleh, Michael Hornberger, Craig Ritchie, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 92
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Jifei Miao, Haixia Ma, Yang Yang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 91
Exploring Sex-Related Differences in Microglia May Be a Game-Changer in Precision Medicine
Marina A. Lynch
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 89
Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
Raquel Sánchez‐Varo, Marina Mejias‐Ortega, Juan José Fernandez-Valenzuela, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5404-5404
Open Access | Times Cited: 81
Apolipoprotein E in lipid metabolism and neurodegenerative disease
Linda Yang, Zachary M. March, Roxan A. Stephenson, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 8, pp. 430-445
Open Access | Times Cited: 75
SERPINA3: Stimulator or Inhibitor of Pathological Changes
Mateusz de Mezer, Jan Rogaliński, Stanisław Przewoźny, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 156-156
Open Access | Times Cited: 54
Effects of a ketogenic and low‐fat diet on the human metabolome, microbiome, and foodome in adults at risk for Alzheimer's disease
Amanda Hazel Dilmore, Cameron Martino, Bryan J. Neth, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 4805-4816
Open Access | Times Cited: 49
Menopausal hormone therapy is associated with worse levels of Alzheimer's disease biomarkers in APOE ε4‐carrying women: An observational study
Ainara Jauregi Zinkunegi, Carey E. Gleason, Barbara B. Bendlin, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 2
Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer’s disease
Alice Taubes, Phil Nova, Kelly A. Zalocusky, et al.
Nature Aging (2021) Vol. 1, Iss. 10, pp. 932-947
Open Access | Times Cited: 87
APOE4 confers transcriptomic and functional alterations to primary mouse microglia
Saima I. Machlovi, Sarah M. Neuner, B Hemmer, et al.
Neurobiology of Disease (2022) Vol. 164, pp. 105615-105615
Open Access | Times Cited: 45
Serpin Signatures in Prion and Alzheimer’s Diseases
Marco Zattoni, Marika Mearelli, Silvia Vanni, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 6, pp. 3778-3799
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top